Go Pro

Atomera (ATOM) Financials

Atomera logo
$6.84 -0.53 (-7.13%)
As of 03:13 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Atomera

Annual Income Statements for Atomera

This table shows Atomera's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-9.51 -13 -13 -13 -13 -15 -16 -17 -20 -18 -20
Consolidated Net Income / (Loss)
-9.51 -13 -13 -13 -13 -15 -16 -17 -20 -18 -20
Net Income / (Loss) Continuing Operations
-9.51 -13 -13 -13 -13 -15 -16 -17 -20 -18 -20
Total Pre-Tax Income
-9.51 -13 -13 -13 -13 -15 -16 -17 -20 -18 -20
Total Operating Income
-5.50 -10.00 -13 -13 -14 -15 -16 -18 -21 -19 -21
Total Gross Profit
0.00 0.00 0.07 0.10 0.28 0.05 0.40 0.30 0.52 0.01 -0.26
Total Revenue
0.00 0.00 0.11 0.25 0.53 0.06 0.40 0.38 0.55 0.14 0.07
Operating Revenue
- 0.00 0.11 0.25 0.53 0.06 0.40 0.38 0.55 0.14 0.07
Total Cost of Revenue
0.00 0.00 0.04 0.15 0.25 0.01 0.00 0.08 0.03 0.12 0.32
Operating Cost of Revenue
- 0.00 0.04 0.15 0.25 0.01 0.00 0.08 0.03 0.12 0.32
Total Operating Expenses
5.50 10.00 13 13 14 15 16 18 21 19 21
Selling, General & Admin Expense
3.44 5.11 5.80 4.96 5.20 5.62 6.16 6.44 7.08 7.27 7.81
Marketing Expense
0.04 0.90 1.66 0.96 0.95 0.92 0.99 1.35 1.60 1.05 0.76
Research & Development Expense
2.02 3.99 5.83 7.32 7.75 8.42 8.78 10 13 11 12
Total Other Income / (Expense), net
-4.01 -2.61 0.14 0.24 0.33 0.04 -0.12 0.09 0.89 0.90 0.95
Interest Expense
1.93 2.64 -0.15 -0.24 - 0.00 0.13 0.26 0.19 0.13 0.06
Interest & Investment Income
0.01 0.03 - - - 0.04 0.01 0.34 0.72 0.78 0.93
Other Income / (Expense), net
-2.09 0.00 -0.01 - 0.33 - - 0.00 0.36 0.25 0.07
Basic Earnings per Share
($7.55) ($2.22) ($1.11) ($1.02) ($0.84) ($0.79) ($0.70) ($0.75) ($0.80) ($0.68) ($0.65)
Weighted Average Basic Shares Outstanding
1.26M 5.68M 11.77M 12.66M 15.85M 18.75M 22.49M 23.16M 24.76M 27.22M 30.84M
Diluted Earnings per Share
($7.55) ($2.22) ($1.11) ($1.02) ($0.84) ($0.79) ($0.70) ($0.75) ($0.80) ($0.68) ($0.65)
Weighted Average Diluted Shares Outstanding
1.26M 5.68M 11.77M 12.66M 15.85M 18.75M 22.49M 23.16M 24.76M 27.22M 30.84M
Weighted Average Basic & Diluted Shares Outstanding
1.26M 5.68M 11.77M 12.66M 15.85M 18.75M 22.49M 23.97M 26.62M 30.70M 38.70M

Quarterly Income Statements for Atomera

This table shows Atomera's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-5.04 -4.58 -4.82 -4.36 -4.60 -4.66 -5.21 -4.97 -5.57 -4.43 -6.07
Consolidated Net Income / (Loss)
-5.04 -4.58 -4.82 -4.36 -4.60 -4.66 -5.21 -4.97 -5.57 -4.43 -6.07
Net Income / (Loss) Continuing Operations
-5.04 -4.58 -4.82 -4.36 -4.60 -4.60 -5.21 -4.97 -5.57 -4.43 -6.07
Total Pre-Tax Income
-5.04 -4.58 -4.82 -4.36 -4.60 -4.60 -5.21 -4.97 -5.57 -4.43 -6.07
Total Operating Income
-5.35 -4.80 -5.03 -4.63 -4.80 -4.87 -5.46 -5.26 -5.79 -4.61 -6.32
Total Gross Profit
0.00 0.52 -0.02 -0.00 0.02 0.01 0.00 -0.06 -0.12 -0.08 -0.12
Total Revenue
0.00 0.55 0.02 0.07 0.02 0.02 0.00 0.00 0.01 0.05 0.01
Operating Revenue
0.00 0.55 0.02 0.07 0.02 0.02 0.00 0.00 0.01 0.05 0.01
Total Cost of Revenue
0.00 0.03 0.03 0.07 0.00 0.01 0.00 0.06 0.13 0.13 0.13
Operating Cost of Revenue
0.00 0.03 0.03 0.07 0.00 0.01 0.00 0.06 0.13 0.13 0.13
Total Operating Expenses
5.35 5.32 5.02 4.63 4.82 4.88 5.47 5.19 5.68 4.53 6.21
Selling, General & Admin Expense
1.68 1.88 1.81 1.83 1.81 1.81 2.09 2.05 2.17 1.51 2.33
Marketing Expense
0.37 0.45 0.35 0.21 0.25 0.25 0.12 0.14 0.21 0.29 0.42
Research & Development Expense
3.31 2.99 2.86 2.59 2.76 2.82 3.26 3.00 3.30 2.74 3.46
Total Other Income / (Expense), net
0.31 0.22 0.21 0.27 0.21 0.26 0.25 0.29 0.22 0.19 0.25
Interest Expense
0.05 0.04 0.04 0.04 0.03 - 0.02 0.02 0.01 0.01 0.00
Interest & Investment Income
0.18 0.20 0.21 0.19 0.18 0.21 0.27 0.23 0.23 0.20 0.20
Other Income / (Expense), net
0.18 - 0.05 0.12 0.06 - 0.01 0.07 0.00 -0.01 0.06
Basic Earnings per Share
($0.20) ($0.18) ($0.19) ($0.16) ($0.17) ($0.16) ($0.17) ($0.17) ($0.17) ($0.14) ($0.17)
Weighted Average Basic Shares Outstanding
25.26M 24.76M 26.04M 26.47M 27.41M 27.22M 30.24M 30.40M 31.13M 30.84M 35.26M
Diluted Earnings per Share
($0.20) ($0.18) ($0.19) ($0.16) ($0.17) ($0.16) ($0.17) ($0.17) ($0.17) ($0.14) ($0.17)
Weighted Average Diluted Shares Outstanding
25.26M 24.76M 26.04M 26.47M 27.41M 27.22M 30.24M 30.40M 31.13M 30.84M 35.26M
Weighted Average Basic & Diluted Shares Outstanding
25.80M 26.62M 26.89M 27.80M 28.78M 30.70M 30.70M 31.48M 31.68M 38.70M 38.72M

Annual Cash Flow Statements for Atomera

This table details how cash moves in and out of Atomera's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
3.18 24 -9.35 1.56 -4.06 23 -9.24 -7.52 -8.59 13 -6.57
Net Cash From Operating Activities
-4.39 -6.80 -9.29 -9.77 -10 -12 -12 -12 -15 -13 -15
Net Cash From Continuing Operating Activities
-4.39 -6.80 -9.29 -9.77 -10 -12 -12 -12 -15 -13 -15
Net Income / (Loss) Continuing Operations
-9.51 -13 -13 -13 -13 -15 -16 -17 -20 -18 -20
Consolidated Net Income / (Loss)
-9.51 -13 -13 -13 -13 -15 -16 -17 -20 -18 -20
Depreciation Expense
0.01 0.02 0.02 0.03 0.04 0.04 0.07 0.08 0.08 0.05 0.05
Amortization Expense
0.22 1.53 - 0.00 0.13 0.14 0.72 1.43 1.11 1.15 1.18
Non-Cash Adjustments To Reconcile Net Income
5.24 3.77 4.08 2.42 2.93 3.04 2.88 3.15 3.46 4.42 4.96
Changes in Operating Assets and Liabilities, net
-0.35 0.50 -0.32 0.66 -0.22 -0.41 -0.40 0.29 0.59 -0.42 -0.89
Net Cash From Investing Activities
-0.00 -0.01 -0.06 -0.02 -0.05 -0.13 -0.11 -0.04 -6.75 6.08 0.95
Net Cash From Continuing Investing Activities
-0.00 -0.01 -0.06 -0.02 -0.05 -0.13 -0.11 -0.04 -6.75 6.08 0.95
Purchase of Property, Plant & Equipment
-0.00 -0.03 -0.06 -0.02 -0.05 -0.13 -0.11 -0.04 -0.03 -0.01 -0.05
Purchase of Investments
- - - - - - - - -20 -5.27 0.00
Sale and/or Maturity of Investments
0.00 0.02 - - - - - 0.00 13 11 1.00
Net Cash From Financing Activities
7.57 30 0.00 11 6.40 35 3.31 5.02 13 20 7.35
Net Cash From Continuing Financing Activities
7.57 30 0.00 11 6.40 35 3.31 5.02 13 20 7.35
Issuance of Common Equity
0.00 28 0.00 11 6.40 33 0.24 - 14 21 7.61
Other Financing Activities, net
0.00 0.00 - - 0.00 1.88 3.06 5.02 -0.79 -0.94 -0.26
Cash Interest Paid
- - - 0.00 0.00 0.00 0.13 0.26 0.19 0.13 0.06
Cash Income Taxes Paid
- - - 0.00 0.00 0.00 0.07 0.00 0.00 0.00 0.00

Quarterly Cash Flow Statements for Atomera

This table details how cash moves in and out of Atomera's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-0.26 -0.05 2.22 -0.32 -0.73 12 -1.66 -2.10 -1.70 -1.11 -5.05
Net Cash From Operating Activities
-3.48 -2.91 -4.15 -3.16 -2.90 -3.03 -4.78 -3.51 -3.36 -3.22 -4.61
Net Cash From Continuing Operating Activities
-3.48 -2.91 -4.15 -3.16 -2.90 -3.03 -4.78 -3.51 -3.36 -3.22 -4.61
Net Income / (Loss) Continuing Operations
-5.04 -4.58 -4.82 -4.36 -4.60 -4.66 -5.21 -4.97 -5.57 -4.43 -6.07
Consolidated Net Income / (Loss)
-5.04 -4.58 -4.82 -4.36 -4.60 -4.66 -5.21 -4.97 -5.57 -4.43 -6.07
Depreciation Expense
0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Amortization Expense
0.23 0.28 0.29 0.30 0.27 0.29 0.31 0.31 0.29 0.28 0.22
Non-Cash Adjustments To Reconcile Net Income
1.04 0.46 1.47 0.92 1.07 0.67 1.01 1.28 1.12 1.55 1.41
Changes in Operating Assets and Liabilities, net
0.27 0.91 -1.11 -0.04 0.34 0.66 -0.90 -0.14 0.79 -0.64 -0.17
Net Cash From Investing Activities
3.25 0.88 2.52 0.68 0.27 2.61 1.00 -0.01 -0.01 -0.02 -27
Net Cash From Continuing Investing Activities
3.25 0.88 2.52 0.68 0.27 2.61 1.00 -0.01 -0.01 -0.02 -27
Purchase of Property, Plant & Equipment
-0.01 - 0.00 -0.01 - -0.01 -0.00 -0.01 -0.01 -0.02 0.00
Purchase of Investments
-5.74 -2.94 -1.48 -2.81 -0.98 - 0.00 - - - -27
Sale and/or Maturity of Investments
9.00 3.80 4.00 3.50 1.25 2.62 1.00 - - - 0.00
Net Cash From Financing Activities
-0.03 1.98 3.84 2.16 1.90 12 2.13 1.42 1.67 2.13 27
Net Cash From Continuing Financing Activities
-0.03 1.98 3.84 2.16 1.90 12 2.13 1.42 1.67 2.13 27
Issuance of Common Equity
- 2.26 3.95 2.45 2.09 13 2.41 0.79 1.97 2.44 3.14
Other Financing Activities, net
-11 -0.28 -0.11 -0.29 -0.20 -0.34 -0.28 0.63 -0.30 -0.31 23
Cash Interest Paid
0.05 0.04 0.03 0.04 0.02 0.04 0.02 0.02 0.01 0.01 0.00
Cash Income Taxes Paid
- - 0.00 - - - 0.00 - - - 0.00

Annual Balance Sheets for Atomera

This table presents Atomera's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
3.42 27 18 19 15 39 36 27 24 29 21
Total Current Assets
3.26 27 18 19 15 38 29 22 20 27 20
Cash & Equivalents
3.20 27 17 19 15 38 29 21 13 26 19
Short-Term Investments
- - - - - - - 0.00 6.94 1.00 0.00
Note & Lease Receivable
- - - - - - - 0.00 0.08 0.07 0.05
Accounts Receivable
- 0.00 0.11 0.19 - - - - 0.55 0.01 0.00
Prepaid Expenses
0.05 0.10 0.25 0.17 0.13 0.13 0.31 0.42 0.24 0.24 0.34
Plant, Property, & Equipment, net
0.02 0.03 0.07 0.06 0.06 0.15 0.20 0.16 0.10 0.06 0.06
Total Noncurrent Assets
0.15 0.04 0.01 0.01 0.17 1.17 6.86 4.97 3.53 1.97 1.43
Noncurrent Note & Lease Receivables
- - - - - 0.00 5.85 4.16 2.90 1.59 0.53
Other Noncurrent Operating Assets
0.15 0.04 0.01 0.01 0.17 1.17 1.01 0.81 0.62 0.39 0.90
Total Liabilities & Shareholders' Equity
3.42 27 18 19 15 39 36 27 24 29 21
Total Liabilities
17 1.03 0.95 1.61 1.47 2.05 7.68 6.42 5.86 4.05 2.71
Total Current Liabilities
17 1.03 0.95 1.61 1.47 1.45 2.75 2.91 3.81 3.58 2.00
Accounts Payable
0.30 0.35 0.20 0.35 0.32 0.44 0.34 0.40 0.62 0.49 0.61
Accrued Expenses
0.13 0.17 0.24 0.22 0.15 0.21 0.20 0.17 0.22 0.24 0.17
Current Deferred Revenue
- - 0.00 0.06 0.04 - - - 0.00 0.00 0.01
Current Employee Benefit Liabilities
0.01 0.51 0.51 0.98 0.82 0.71 0.60 0.97 1.38 1.33 0.65
Other Current Liabilities
- - - 0.00 0.15 0.09 1.61 1.37 1.59 1.51 0.57
Total Noncurrent Liabilities
0.00 0.00 0.00 0.00 0.00 0.60 4.93 3.51 2.05 0.47 0.71
Other Noncurrent Operating Liabilities
- - - - 0.00 0.60 4.93 0.52 0.30 0.02 0.71
Commitments & Contingencies
0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-13 26 17 18 14 37 28 20 18 25 18
Total Preferred & Common Equity
-13 26 17 18 14 37 28 20 18 25 18
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-13 26 17 18 14 37 28 20 18 25 18
Common Stock
70 122 126 140 149 187 194 204 221 247 260
Retained Earnings
-83 -96 -109 -122 -135 -150 -166 -183 -203 -222 -242
Accumulated Other Comprehensive Income / (Loss)
- - - - - - - - 0.00 0.00 0.00

Quarterly Balance Sheets for Atomera

This table presents Atomera's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
25 23 22 20 26 24 22 44
Total Current Assets
21 20 19 18 25 23 21 42
Cash & Equivalents
13 15 14 14 24 22 20 14
Short-Term Investments
7.75 4.46 3.80 3.59 0.00 0.00 0.00 27
Note & Lease Receivable
0.06 0.07 0.07 0.06 0.08 0.06 0.06 0.14
Accounts Receivable
- - 0.01 0.01 0.00 0.00 0.14 0.04
Prepaid Expenses
0.39 0.33 0.58 0.39 0.34 0.66 0.52 0.79
Plant, Property, & Equipment, net
0.13 0.08 0.08 0.06 0.05 0.05 0.05 0.05
Total Noncurrent Assets
3.86 3.19 2.85 2.29 1.66 1.29 0.85 1.51
Noncurrent Note & Lease Receivables
3.18 2.62 2.34 1.84 1.34 1.09 0.74 0.32
Other Noncurrent Operating Assets
0.68 0.56 0.51 0.45 0.32 0.20 0.11 1.19
Total Liabilities & Shareholders' Equity
25 23 22 20 26 24 22 44
Total Liabilities
5.37 4.53 4.39 4.25 2.97 2.79 2.91 3.07
Total Current Liabilities
2.95 2.90 3.14 3.39 2.86 2.79 2.91 2.18
Accounts Payable
0.46 0.60 0.65 0.79 0.76 0.67 0.62 0.68
Accrued Expenses
0.23 0.21 0.25 0.17 0.20 0.21 0.24 0.21
Current Deferred Revenue
- 0.02 0.01 0.01 0.00 0.00 0.14 0.10
Current Employee Benefit Liabilities
0.70 0.45 0.59 0.97 0.40 0.65 1.11 0.78
Other Current Liabilities
1.56 1.62 1.64 1.45 1.50 1.27 0.79 0.41
Total Noncurrent Liabilities
2.41 1.63 1.25 0.86 0.11 0.00 0.00 0.90
Other Noncurrent Operating Liabilities
0.35 0.19 0.14 0.08 0.00 0.00 0.00 0.90
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
19 18 17 16 23 21 19 41
Total Preferred & Common Equity
19 18 17 16 23 21 19 41
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
19 18 17 16 23 21 19 41
Common Stock
218 226 230 233 250 253 256 288
Retained Earnings
-199 -208 -212 -217 -227 -232 -237 -248
Accumulated Other Comprehensive Income / (Loss)
-0.00 -0.00 -0.01 0.00 0.00 0.00 0.00 -0.02

Annual Metrics And Ratios for Atomera

This table displays calculated financial ratios and metrics derived from Atomera's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 123.64% 116.67% -88.37% 545.16% -4.50% 43.98% -75.45% -51.85%
EBITDA Growth
0.00% -15.01% -56.03% 0.74% -0.17% -12.34% -0.02% -8.65% -19.44% 6.55% -10.84%
EBIT Growth
0.00% -31.77% -32.17% 0.63% -1.27% -12.18% -4.08% -12.86% -15.94% 6.07% -10.30%
NOPAT Growth
0.00% -81.83% -32.11% 0.58% -3.75% -9.50% -4.08% -12.86% -17.98% 6.49% -9.24%
Net Income Growth
0.00% -32.56% -3.63% 1.31% -3.12% -11.86% -5.62% -10.99% -13.47% 6.85% -9.43%
EPS Growth
0.00% 70.60% 50.00% 8.11% 17.65% 5.95% 11.39% -7.14% -6.67% 15.00% 4.41%
Operating Cash Flow Growth
0.00% -54.98% -36.62% -5.21% -6.50% -15.94% -3.10% -0.47% -16.47% 9.07% -12.35%
Free Cash Flow Firm Growth
0.00% 0.00% -50.86% 11.34% -13.01% -13.72% -1.86% -31.87% 13.30% 6.65% -27.77%
Invested Capital Growth
0.00% -265.55% 41.26% -132.29% 7.41% 45.68% 46.73% 765.41% -81.62% -420.57% 33.52%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 19.42% -2.20% -69.00% 0.00% 1.33% 10,900.00% -79.61% 71.05%
EBITDA Q/Q Growth
0.00% 0.00% 5.60% -5.09% 4.69% -5.56% 0.69% -1.98% -0.50% 0.97% 1.09%
EBIT Q/Q Growth
0.00% 0.00% 5.59% -5.11% 3.69% -5.45% -1.28% -1.94% -0.16% 0.91% 1.07%
NOPAT Q/Q Growth
0.00% 0.00% 5.59% -5.11% 1.33% -5.45% -1.28% -1.94% -1.93% -0.39% 1.22%
Net Income Q/Q Growth
0.00% 0.00% 5.79% -4.79% 1.14% -5.91% -1.97% -0.54% -1.58% -0.42% 1.14%
EPS Q/Q Growth
0.00% 0.00% -288.14% -0.99% 5.62% 0.00% -1.45% 1.32% -1.27% 2.86% 2.99%
Operating Cash Flow Q/Q Growth
0.00% -2.89% -8.48% -2.34% 4.48% -9.24% -0.70% 0.94% 0.07% -0.91% -1.32%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% -1.29% 4.08% -9.79% 27.82% -39.58% -0.41% -1.93% -6.00%
Invested Capital Q/Q Growth
0.00% 0.00% 22.81% -18.70% -74.17% -5.66% -107.67% -20.03% -65.91% -86.68% 35.84%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
0.00% 0.00% 64.55% 39.84% 52.53% 79.03% 100.00% 78.80% 94.91% 8.89% -393.85%
EBITDA Margin
0.00% 0.00% -11,997.27% -5,325.20% -2,461.91% -23,775.81% -3,686.00% -4,193.72% -3,478.91% -13,245.19% -30,492.31%
Operating Margin
0.00% 0.00% -12,009.09% -5,338.62% -2,556.29% -24,064.52% -3,882.25% -4,587.96% -3,759.45% -14,322.96% -32,496.92%
EBIT Margin
0.00% 0.00% -12,014.55% -5,338.62% -2,495.31% -24,064.52% -3,882.25% -4,587.96% -3,694.36% -14,137.04% -32,386.15%
Profit (Net Income) Margin
0.00% 0.00% -11,880.00% -5,242.68% -2,495.31% -23,996.77% -3,928.50% -4,565.71% -3,598.18% -13,655.56% -31,036.92%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.42% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
125.37% 126.11% 98.88% 98.20% 100.00% 99.72% 100.77% 99.52% 97.40% 96.59% 95.83%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1,364.65% -1,155.60% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1,342.59% -1,126.05% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1,293.02% 1,052.75% 0.00% 0.00%
Return on Equity (ROE)
72.50% -198.16% -61.20% -74.54% -84.40% -58.21% -47.82% -71.63% -102.85% -85.25% -92.84%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -694.81% -1,017.72% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% -59.15% -70.68% -76.89% -54.62% -41.16% -55.83% -80.06% -71.81% -83.84%
Return on Assets (ROA)
0.00% 0.00% -58.49% -69.41% -76.89% -54.46% -41.65% -55.55% -77.98% -69.37% -80.35%
Return on Common Equity (ROCE)
72.50% -198.16% -61.20% -74.54% -84.40% -58.21% -47.82% -71.63% -102.85% -85.25% -92.84%
Return on Equity Simple (ROE_SIMPLE)
72.50% -48.79% -77.52% -72.68% -96.57% -39.84% -55.37% -85.86% -108.92% -73.51% 0.00%
Net Operating Profit after Tax (NOPAT)
-3.85 -7.00 -9.25 -9.19 -9.54 -10 -11 -12 -14 -14 -15
NOPAT Margin
0.00% 0.00% -8,406.36% -3,737.03% -1,789.40% -16,845.16% -2,717.58% -3,211.57% -2,631.62% -10,026.07% -22,747.85%
Net Nonoperating Expense Percent (NNEP)
43.96% -81.11% -17.33% -20.41% -22.26% -16.79% -14.54% -22.06% -29.55% -22.22% -23.67%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - -72.66% -53.03% -80.44%
Cost of Revenue to Revenue
0.00% 0.00% 35.45% 60.16% 47.47% 20.97% 0.00% 21.20% 5.09% 91.11% 493.85%
SG&A Expenses to Revenue
0.00% 0.00% 5,269.09% 2,014.63% 976.17% 9,070.97% 1,541.00% 1,686.13% 1,286.36% 5,382.22% 12,009.23%
R&D to Revenue
0.00% 0.00% 5,296.36% 2,974.80% 1,453.66% 13,587.10% 2,194.75% 2,627.75% 2,277.27% 8,169.63% 18,927.69%
Operating Expenses to Revenue
0.00% 0.00% 12,073.64% 5,378.46% 2,608.82% 24,143.55% 3,982.25% 4,666.75% 3,854.36% 14,331.85% 32,103.08%
Earnings before Interest and Taxes (EBIT)
-7.59 -10.00 -13 -13 -13 -15 -16 -18 -20 -19 -21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-7.35 -8.46 -13 -13 -13 -15 -15 -16 -19 -18 -20
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 3.14 3.12 2.43 3.83 9.24 16.42 7.30 9.95 13.31 3.81
Price to Tangible Book Value (P/TBV)
0.00 3.14 3.12 2.43 3.83 9.24 16.42 7.30 9.95 13.31 3.81
Price to Revenue (P/Rev)
0.00 0.00 478.69 175.39 98.91 5,567.99 1,164.84 388.40 328.82 2,472.79 1,077.16
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 61.52 419.20 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 320.79 98.43 71.01 4,956.02 1,093.09 340.76 296.49 2,277.79 781.62
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-1.23 0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.10 0.02 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.10 0.02 0.00
Financial Leverage
-0.98 -1.09 -1.03 -1.05 -1.07 -1.03 -1.01 -0.96 -0.93 -1.02 -1.05
Leverage Ratio
-0.26 2.38 1.05 1.07 1.10 1.07 1.15 1.29 1.32 1.23 1.16
Compound Leverage Factor
-0.33 3.00 1.03 1.05 1.10 1.07 1.16 1.28 1.28 1.19 1.11
Debt to Total Capital
541.19% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 12.82% 8.79% 1.76% 0.00%
Short-Term Debt to Total Capital
541.19% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 12.82% 8.79% 1.76% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-441.19% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 87.18% 91.21% 98.24% 100.00%
Debt to EBITDA
-2.19 0.00 0.00 0.00 0.00 0.00 0.00 -0.19 -0.09 -0.03 0.00
Net Debt to EBITDA
-1.75 0.00 0.00 0.00 0.00 0.00 0.00 1.14 0.93 1.47 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.19 -0.09 -0.03 0.00
Debt to NOPAT
-4.18 0.00 0.00 0.00 0.00 0.00 0.00 -0.24 -0.12 -0.03 0.00
Net Debt to NOPAT
-3.35 0.00 0.00 0.00 0.00 0.00 0.00 1.48 1.23 1.94 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.24 -0.12 -0.03 0.00
Altman Z-Score
0.00 42.16 23.40 6.12 7.34 95.57 29.43 2.97 4.75 37.65 -2.84
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.20 26.01 18.68 11.97 10.22 26.29 10.54 7.43 5.35 7.58 9.80
Quick Ratio
0.19 25.91 18.42 11.87 10.13 26.20 10.42 7.28 5.29 7.51 9.63
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -6.37 -9.61 -8.52 -9.63 -11 -11 -15 -13 -12 -15
Operating Cash Flow to CapEx
-109,675.00% -24,282.14% -15,481.67% -42,491.30% -20,407.84% -9,211.45% -11,413.76% -32,048.72% -90,981.25% -94,542.86% -30,348.98%
Free Cash Flow to Firm to Interest Expense
0.00 -2.41 0.00 0.00 0.00 0.00 -87.10 -57.66 -65.71 -92.24 -253.40
Operating Cash Flow to Interest Expense
-2.27 -2.58 0.00 0.00 0.00 0.00 -97.20 -49.02 -75.04 -102.60 -247.85
Operating Cash Flow Less CapEx to Interest Expense
-2.28 -2.59 0.00 0.00 0.00 0.00 -98.05 -49.17 -75.12 -102.71 -248.67
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.01 0.03 0.00 0.01 0.01 0.02 0.01 0.00
Accounts Receivable Turnover
0.00 0.00 0.00 1.67 0.00 0.00 0.00 0.00 0.00 0.49 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 2.32 4.00 8.96 0.57 2.29 2.16 4.26 1.70 1.09
Accounts Payable Turnover
0.00 0.00 0.14 0.54 0.76 0.03 0.00 0.22 0.06 0.22 0.58
Days Sales Outstanding (DSO)
0.00 0.00 0.00 218.85 0.00 0.00 0.00 0.00 0.00 751.63 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 2,578.40 673.28 478.25 10,627.12 0.00 1,656.02 6,615.63 1,646.95 625.39
Cash Conversion Cycle (CCC)
0.00 0.00 -2,578.40 -454.43 -478.25 -10,627.12 0.00 -1,656.02 -6,615.63 -895.32 -625.39
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-0.24 -0.87 -0.51 -1.19 -1.10 -0.60 -0.32 2.12 0.39 -1.25 -0.83
Invested Capital Turnover
0.00 0.00 -0.16 -0.29 -0.47 -0.07 -0.87 0.42 0.44 -0.31 -0.06
Increase / (Decrease) in Invested Capital
0.00 -0.63 0.36 -0.68 0.09 0.50 0.28 2.43 -1.73 -1.64 0.42
Enterprise Value (EV)
0.00 54 35 24 38 307 437 130 163 308 51
Market Capitalization
0.00 81 53 43 53 345 466 148 181 334 70
Book Value per Share
($10.41) $2.15 $1.39 $1.18 $0.80 $1.74 $1.23 $0.85 $0.70 $0.87 $0.58
Tangible Book Value per Share
($10.41) $2.15 $1.39 $1.18 $0.80 $1.74 $1.23 $0.85 $0.70 $0.87 $0.58
Total Capital
2.97 26 17 18 14 37 28 23 20 26 18
Total Debt
16 0.00 0.00 0.00 0.00 0.00 0.00 2.99 1.75 0.45 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.99 1.75 0.45 0.00
Net Debt
13 -27 -17 -19 -15 -38 -29 -18 -18 -26 -19
Capital Expenditures (CapEx)
0.00 0.03 0.06 0.02 0.05 0.13 0.11 0.04 0.02 0.01 0.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.40 -0.94 -0.59 -1.26 -1.34 -1.32 -2.44 -2.49 -2.94 -3.26 -1.61
Debt-free Net Working Capital (DFNWC)
2.81 26 17 18 14 37 26 19 17 24 18
Net Working Capital (NWC)
-13 26 17 18 14 37 26 19 17 24 18
Net Nonoperating Expense (NNE)
5.66 5.61 3.82 3.70 3.76 4.43 4.84 5.17 5.32 4.90 5.39
Net Nonoperating Obligations (NNO)
13 -27 -17 -19 -15 -38 -29 -18 -18 -26 -19
Total Depreciation and Amortization (D&A)
0.23 1.54 0.02 0.03 0.18 0.18 0.79 1.51 1.19 1.20 1.23
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% -537.27% -510.57% -250.66% -2,122.58% -611.00% -651.83% -534.73% -2,412.59% -2,473.85%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 15,252.73% 7,185.77% 2,539.40% 59,074.19% 6,563.75% 4,893.72% 3,016.36% 17,419.26% 27,080.00%
Net Working Capital to Revenue
0.00% 0.00% 15,252.73% 7,185.77% 2,539.40% 59,074.19% 6,563.75% 4,893.72% 3,016.36% 17,419.26% 27,080.00%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($7.55) ($2.22) ($1.08) ($1.02) ($0.84) ($0.79) ($0.70) ($0.75) ($0.80) ($0.68) ($0.65)
Adjusted Weighted Average Basic Shares Outstanding
1.26M 12.10M 12.36M 15.33M 17.31M 22.62M 23.23M 23.16M 24.76M 27.22M 30.84M
Adjusted Diluted Earnings per Share
($7.55) ($2.22) ($1.08) ($1.02) ($0.84) ($0.79) ($0.70) ($0.75) ($0.80) ($0.68) ($0.65)
Adjusted Weighted Average Diluted Shares Outstanding
1.26M 12.10M 12.36M 15.33M 17.31M 22.62M 23.23M 23.16M 24.76M 27.22M 30.84M
Adjusted Basic & Diluted Earnings per Share
($7.55) ($2.22) ($1.08) ($1.02) ($0.84) ($0.79) ($0.70) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.26M 5.68M 12.12M 12.66M 15.85M 18.75M 22.49M 23.97M 26.62M 30.70M 38.70M
Normalized Net Operating Profit after Tax (NOPAT)
-3.85 -7.00 -9.25 -9.19 -9.54 -10 -11 -12 -14 -14 -15
Normalized NOPAT Margin
0.00% 0.00% -8,406.36% -3,737.03% -1,789.40% -16,845.16% -2,717.58% -3,211.57% -2,631.62% -10,026.07% -22,747.85%
Pre Tax Income Margin
0.00% 0.00% -11,880.00% -5,242.68% -2,495.31% -23,996.77% -3,912.00% -4,565.71% -3,598.18% -13,655.56% -31,036.92%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-3.93 -3.79 0.00 0.00 0.00 0.00 -121.32 -68.73 -104.74 -147.95 -350.85
NOPAT to Interest Expense
-1.99 -2.65 0.00 0.00 0.00 0.00 -84.92 -48.11 -74.61 -104.92 -246.44
EBIT Less CapEx to Interest Expense
-3.93 -3.80 0.00 0.00 0.00 0.00 -122.17 -68.88 -104.82 -148.05 -351.67
NOPAT Less CapEx to Interest Expense
-2.00 -2.66 0.00 0.00 0.00 0.00 -85.78 -48.26 -74.69 -105.03 -247.25
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-1.52% -21.71% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Atomera

This table displays calculated financial ratios and metrics derived from Atomera's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
25,793,907.00 25,799,018.00 25,799,018.00 26,887,371.00 27,804,438.00 - 30,703,865.00 30,704,132.00 31,482,756.00 - 38,696,147.00
DEI Adjusted Shares Outstanding
25,793,907.00 25,799,018.00 25,799,018.00 26,887,371.00 27,804,438.00 - 30,703,865.00 30,704,132.00 31,482,756.00 - 38,696,147.00
DEI Earnings Per Adjusted Shares Outstanding
-0.20 -0.18 -0.19 -0.16 -0.17 - -0.17 -0.16 -0.18 - -0.16
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-100.00% 10,900.00% 0.00% 0.00% 0.00% -95.82% -77.78% -100.00% -50.00% 117.39% 175.00%
EBITDA Growth
-14.72% -11.20% 2.68% 15.65% 9.38% -1.69% -9.88% -15.64% -23.29% 4.79% -17.43%
EBIT Growth
-11.04% -8.87% 3.46% 14.13% 8.28% -1.56% -9.42% -14.90% -22.19% 4.71% -14.80%
NOPAT Growth
-14.99% -8.87% 2.57% 13.62% 10.33% -1.56% -8.52% -13.50% -20.69% 5.34% -15.76%
Net Income Growth
-9.50% -7.21% 3.93% 15.35% 8.81% -1.68% -8.03% -13.90% -21.28% 4.98% -16.59%
EPS Growth
0.00% -5.88% 9.52% 23.81% 15.00% 11.11% 10.53% -6.25% 0.00% 12.50% 0.00%
Operating Cash Flow Growth
-17.23% 0.34% 2.01% 19.65% 16.74% -4.13% -15.26% -10.78% -16.13% -6.41% 3.66%
Free Cash Flow Firm Growth
-27.65% 70.45% -406.13% 5.08% 30.82% -8.80% 45.35% -42.87% -121.22% -105.50% -82.86%
Invested Capital Growth
-56.88% -81.62% 210.60% -82.30% -158.55% -420.57% -226.66% -345.82% -93.41% 33.52% 25.72%
Revenue Q/Q Growth
0.00% 0.00% -96.73% 300.00% -69.44% 4.55% -82.61% -100.00% 0.00% 354.55% -78.00%
EBITDA Q/Q Growth
1.25% 8.52% -4.00% 10.22% -6.10% -2.65% -13.04% 5.51% -13.12% 21.21% -39.43%
EBIT Q/Q Growth
1.60% 7.20% -3.98% 9.56% -5.10% -2.76% -12.65% 5.04% -11.77% 20.30% -35.72%
NOPAT Q/Q Growth
0.13% 10.39% -4.94% 8.03% -3.67% -1.50% -12.13% 3.81% -10.24% 20.39% -37.12%
Net Income Q/Q Growth
2.19% 9.11% -5.28% 9.56% -5.37% -1.35% -11.85% 4.65% -12.20% 20.60% -37.24%
EPS Q/Q Growth
4.76% 10.00% -5.56% 15.79% -6.25% 5.88% -6.25% 0.00% 0.00% 17.65% -21.43%
Operating Cash Flow Q/Q Growth
11.71% 16.36% -42.68% 23.74% 8.50% -4.59% -57.93% 26.70% 4.08% 4.16% -42.99%
Free Cash Flow Firm Q/Q Growth
-14.98% 27.26% -183.08% 59.91% 16.21% -14.40% -42.19% -4.81% -29.74% -6.28% -26.53%
Invested Capital Q/Q Growth
-32.45% -65.91% 47.56% -47.91% -323.41% -86.68% 41.70% -1.10% -75.78% 35.84% 34.86%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
0.00% 94.91% -83.33% -2.78% 86.36% 43.48% 100.00% 0.00% -1,063.64% -162.00% -1,045.45%
EBITDA Margin
0.00% -817.82% -25,988.89% -5,833.33% -20,254.55% -19,886.96% -128,500.00% 0.00% -49,945.45% -8,658.00% -54,872.73%
Operating Margin
0.00% -872.18% -27,966.67% -6,430.56% -21,818.18% -21,182.61% -136,575.00% 0.00% -52,663.64% -9,224.00% -57,490.91%
EBIT Margin
0.00% -872.18% -27,711.11% -6,265.28% -21,550.00% -21,182.61% -136,450.00% 0.00% -52,663.64% -9,234.00% -56,963.64%
Profit (Net Income) Margin
0.00% -832.73% -26,788.89% -6,056.94% -20,886.36% -20,247.83% -130,225.00% 0.00% -50,663.64% -8,850.00% -55,209.09%
Tax Burden Percent
100.00% 100.04% 100.00% 100.00% 100.00% 101.26% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
97.49% 95.43% 96.67% 96.67% 96.92% 94.40% 95.44% 95.83% 96.20% 95.84% 96.92%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -268.10% -404,347.15% -2,898.28% -42,750.72% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -261.30% -404,339.71% -2,892.49% -42,743.64% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 244.29% 403,703.23% 2,751.27% 42,171.82% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% -23.80% -643.92% -147.01% -578.90% -85.25% -90.30% -100.22% -116.86% -92.84% -65.92%
Cash Return on Invested Capital (CROIC)
-670.46% -1,017.72% -2,695.78% -1,255.51% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% -18.90% -698.48% -157.69% -634.49% -107.60% -671.35% 0.00% -95.11% -23.90% -117.40%
Return on Assets (ROA)
0.00% -18.05% -675.24% -152.44% -614.95% -102.85% -640.72% 0.00% -91.50% -22.91% -113.78%
Return on Common Equity (ROCE)
0.00% -23.80% -643.92% -147.01% -578.90% -85.25% -90.30% -100.22% -116.86% -92.84% -65.92%
Return on Equity Simple (ROE_SIMPLE)
-100.09% 0.00% -106.44% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-3.75 -3.36 -3.52 -3.24 -3.36 -3.41 -3.82 -3.68 -4.06 -3.23 -4.43
NOPAT Margin
0.00% -610.53% -19,576.67% -4,501.39% -15,272.73% -14,827.83% -95,602.50% 0.00% -36,864.55% -6,456.80% -40,243.64%
Net Nonoperating Expense Percent (NNEP)
-6.74% -6.79% -7.44% -5.78% -7.08% -5.65% -6.62% -6.57% -8.23% -5.26% -5.06%
Return On Investment Capital (ROIC_SIMPLE)
- -16.86% -17.76% -17.44% -20.15% -13.36% -16.35% -17.28% -21.31% -17.56% -10.92%
Cost of Revenue to Revenue
0.00% 5.09% 183.33% 102.78% 13.64% 56.52% 0.00% 0.00% 1,163.64% 262.00% 1,145.45%
SG&A Expenses to Revenue
0.00% 340.91% 10,061.11% 2,544.44% 8,236.36% 7,873.91% 52,200.00% 0.00% 19,681.82% 3,010.00% 21,209.09%
R&D to Revenue
0.00% 544.00% 15,877.78% 3,595.83% 12,540.91% 12,273.91% 81,375.00% 0.00% 30,036.36% 5,480.00% 31,427.27%
Operating Expenses to Revenue
0.00% 967.09% 27,883.33% 6,427.78% 21,904.55% 21,226.09% 136,675.00% 0.00% 51,600.00% 9,062.00% 56,445.45%
Earnings before Interest and Taxes (EBIT)
-5.17 -4.80 -4.99 -4.51 -4.74 -4.87 -5.46 -5.18 -5.79 -4.62 -6.27
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-4.92 -4.50 -4.68 -4.20 -4.46 -4.57 -5.14 -4.86 -5.49 -4.33 -6.04
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
8.30 9.95 8.63 5.86 4.60 13.31 5.27 7.27 7.31 3.81 3.64
Price to Tangible Book Value (P/TBV)
8.30 9.95 8.63 5.86 4.60 13.31 5.27 7.27 7.31 3.81 3.64
Price to Revenue (P/Rev)
32,293.97 328.82 279.79 160.06 110.46 2,472.79 1,015.00 3,158.14 3,661.94 1,077.16 2,047.67
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
125.46 419.20 245.80 285.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
28,629.37 296.49 248.40 133.22 85.45 2,277.79 816.57 2,708.63 3,127.15 781.62 1,476.98
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.11 0.10 0.08 0.06 0.05 0.02 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.11 0.10 0.08 0.06 0.05 0.02 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.91 -0.93 -1.00 -0.95 -0.99 -1.02 -1.00 -1.01 -1.06 -1.05 -1.02
Leverage Ratio
1.29 1.32 1.29 1.25 1.27 1.23 1.18 1.19 1.21 1.16 1.09
Compound Leverage Factor
1.25 1.26 1.25 1.21 1.23 1.16 1.13 1.14 1.16 1.11 1.06
Debt to Total Capital
9.60% 8.79% 7.21% 5.96% 4.68% 1.76% 0.48% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
9.60% 8.79% 7.21% 5.96% 4.68% 1.76% 0.48% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
90.40% 91.21% 92.79% 94.04% 95.32% 98.24% 99.52% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
-0.11 -0.09 -0.07 -0.06 -0.04 -0.03 -0.01 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.96 0.93 0.92 0.92 0.92 1.47 1.31 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
-0.11 -0.09 -0.07 -0.06 -0.04 -0.03 -0.01 0.00 0.00 0.00 0.00
Debt to NOPAT
-0.15 -0.12 -0.10 -0.08 -0.06 -0.03 -0.01 0.00 0.00 0.00 0.00
Net Debt to NOPAT
1.29 1.23 1.24 1.24 1.23 1.94 1.74 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
-0.15 -0.12 -0.10 -0.08 -0.06 -0.03 -0.01 0.00 0.00 0.00 0.00
Altman Z-Score
7.04 6.88 8.56 0.63 -4.63 39.27 13.04 20.06 13.66 -0.27 21.48
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
7.06 5.35 6.78 6.03 5.25 7.58 8.59 8.14 7.23 9.80 19.34
Quick Ratio
6.93 5.29 6.66 5.84 5.14 7.51 8.47 7.91 7.05 9.63 18.97
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-2.24 -1.63 -4.62 -1.85 -1.55 -1.77 -2.52 -2.64 -3.43 -3.65 -4.61
Operating Cash Flow to CapEx
-26,746.15% 0.00% 0.00% -52,733.33% 0.00% -37,850.00% -119,550.00% -35,050.00% -25,861.54% -14,645.45% 0.00%
Free Cash Flow to Firm to Interest Expense
-47.70 -37.93 -118.38 -52.89 -51.70 0.00 -120.15 -146.92 -285.93 -405.16 -1,153.45
Operating Cash Flow to Interest Expense
-73.98 -67.63 -106.38 -90.40 -96.50 0.00 -227.71 -194.72 -280.17 -358.00 -1,151.75
Operating Cash Flow Less CapEx to Interest Expense
-74.26 -67.63 -106.38 -90.57 -96.50 0.00 -227.90 -195.28 -281.25 -360.44 -1,151.75
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.02 0.03 0.03 0.03 0.01 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.49 0.00 0.00 0.53 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.03 4.26 4.81 6.10 6.90 1.70 1.79 0.78 0.67 1.09 1.40
Accounts Payable Turnover
0.00 0.06 0.12 0.22 0.22 0.22 0.13 0.12 0.29 0.58 0.62
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 751.63 0.00 0.00 686.78 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 6,615.63 3,063.61 1,633.04 1,650.43 1,646.95 2,761.83 3,067.40 1,261.32 625.39 587.10
Cash Conversion Cycle (CCC)
0.00 -6,615.63 -3,063.61 -1,633.04 -1,650.43 -895.32 -2,761.83 -3,067.40 -574.54 -625.39 -587.10
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1.14 0.39 0.57 0.30 -0.67 -1.25 -0.73 -0.74 -1.29 -0.83 -0.54
Invested Capital Turnover
0.00 0.44 20.65 0.64 2.80 -0.31 -1.58 -0.22 -0.04 -0.06 -0.11
Increase / (Decrease) in Invested Capital
-1.51 -1.73 1.09 -1.39 -1.81 -1.64 -1.30 -1.03 -0.62 0.42 0.19
Enterprise Value (EV)
143 163 141 85 57 308 99 133 119 51 106
Market Capitalization
161 181 159 102 73 334 123 155 139 70 147
Book Value per Share
$0.75 $0.70 $0.71 $0.65 $0.57 $0.87 $0.76 $0.69 $0.60 $0.58 $1.05
Tangible Book Value per Share
$0.75 $0.70 $0.71 $0.65 $0.57 $0.87 $0.76 $0.69 $0.60 $0.58 $1.05
Total Capital
22 20 20 19 17 26 23 21 19 18 41
Total Debt
2.07 1.75 1.43 1.11 0.78 0.45 0.11 0.00 0.00 0.00 0.00
Total Long-Term Debt
2.07 1.75 1.43 1.11 0.78 0.45 0.11 0.00 0.00 0.00 0.00
Net Debt
-18 -18 -18 -17 -17 -26 -24 -22 -20 -19 -41
Capital Expenditures (CapEx)
0.01 0.00 0.00 0.01 0.00 0.01 0.00 0.01 0.01 0.02 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-2.50 -2.94 -2.50 -2.49 -2.94 -3.26 -2.44 -2.07 -2.19 -1.61 -1.21
Debt-free Net Working Capital (DFNWC)
18 17 17 16 14 24 22 20 18 18 40
Net Working Capital (NWC)
18 17 17 16 14 24 22 20 18 18 40
Net Nonoperating Expense (NNE)
1.29 1.22 1.30 1.12 1.24 1.25 1.38 1.29 1.52 1.20 1.65
Net Nonoperating Obligations (NNO)
-18 -18 -18 -17 -17 -26 -24 -22 -20 -19 -41
Total Depreciation and Amortization (D&A)
0.25 0.30 0.31 0.31 0.29 0.30 0.32 0.33 0.30 0.29 0.23
Debt-free, Cash-free Net Working Capital to Revenue
-50,060.00% -534.73% -440.32% -388.44% -443.50% -2,412.59% -2,016.53% -4,226.53% -5,771.05% -2,473.85% -1,676.39%
Debt-free Net Working Capital to Revenue
357,720.00% 3,016.36% 2,951.23% 2,469.06% 2,176.13% 17,419.26% 17,919.83% 40,724.49% 47,707.89% 27,080.00% 55,393.06%
Net Working Capital to Revenue
357,720.00% 3,016.36% 2,951.23% 2,469.06% 2,176.13% 17,419.26% 17,919.83% 40,724.49% 47,707.89% 27,080.00% 55,393.06%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.20) ($0.18) ($0.19) ($0.16) ($0.17) ($0.16) ($0.17) ($0.17) ($0.17) ($0.14) ($0.17)
Adjusted Weighted Average Basic Shares Outstanding
25.26M 24.76M 26.04M 26.47M 27.41M 27.22M 30.24M 30.40M 31.13M 30.84M 35.26M
Adjusted Diluted Earnings per Share
($0.20) ($0.18) ($0.19) ($0.16) ($0.17) ($0.16) ($0.17) ($0.17) ($0.17) ($0.14) ($0.17)
Adjusted Weighted Average Diluted Shares Outstanding
25.26M 24.76M 26.04M 26.47M 27.41M 27.22M 30.24M 30.40M 31.13M 30.84M 35.26M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
25.80M 26.62M 26.89M 27.80M 28.78M 30.70M 30.70M 31.48M 31.68M 38.70M 38.72M
Normalized Net Operating Profit after Tax (NOPAT)
-3.75 -3.36 -3.52 -3.24 -3.36 -3.41 -3.82 -3.68 -4.06 -3.23 -4.43
Normalized NOPAT Margin
0.00% -610.53% -19,576.67% -4,501.39% -15,272.73% -14,827.83% -95,602.50% 0.00% -36,864.55% -6,456.80% -40,243.64%
Pre Tax Income Margin
0.00% -832.36% -26,788.89% -6,056.94% -20,886.36% -19,995.65% -130,225.00% 0.00% -50,663.64% -8,850.00% -55,209.09%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-109.98 -111.56 -127.90 -128.89 -158.03 0.00 -259.90 -287.94 -482.75 -513.00 -1,566.50
NOPAT to Interest Expense
-79.73 -78.09 -90.35 -92.60 -112.00 0.00 -182.10 -204.36 -337.93 -358.71 -1,106.70
EBIT Less CapEx to Interest Expense
-110.26 -111.56 -127.90 -129.06 -158.03 0.00 -260.10 -288.50 -483.83 -515.44 -1,566.50
NOPAT Less CapEx to Interest Expense
-80.00 -78.09 -90.35 -92.77 -112.00 0.00 -182.29 -204.92 -339.01 -361.16 -1,106.70
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Atomera’s latest quarter shows a company with a very strong balance sheet, but ongoing heavy cash burn and limited revenue traction. Over the past four years, the big story has not changed much: Atomera remains a pre-commercial or early-commercial business with small and lumpy revenue, meaningful R&D and operating expenses, and persistent net losses. The good news is that the company still holds substantial cash and short-term investments. The challenge is that operating cash flow remains deeply negative, so investors are still watching how long the balance sheet can support the business while it tries to scale.

What stands out from Q1 2026: revenue was just $11,000, gross profit was negative, and the company reported a net loss of $6.1 million. Operating cash flow was negative $4.6 million, and even after financing inflows, cash and equivalents fell by $5.0 million during the quarter. At the same time, total cash and short-term investments were still about $41.1 million, which gives Atomera a meaningful cushion.

  • Strong liquidity cushion: As of Q1 2026, Atomera had $14.2 million in cash and equivalents plus $26.9 million in short-term investments, or about $41.1 million in liquid resources.
  • Minimal debt burden: Total liabilities were only $3.1 million, which keeps the balance sheet relatively clean and reduces financial risk.
  • Equity base remains solid: Total common equity was $40.6 million in Q1 2026, supported by a large common stock balance and limited liabilities.
  • Interest and investment income helps offset losses: Q1 2026 included $197,000 of interest and investment income, which partially softened the operating loss.
  • Revenue is still extremely small and uneven: Quarterly revenue has ranged from $0 to $72,000 in the 2024-2026 period shown, with no clear sign of sustained scale yet.
  • Other income can swing results: Atomera’s non-operating items have helped in some quarters, but these are not a dependable source of earnings power.
  • Persistent operating losses: Q1 2026 operating loss was $6.3 million, and losses have generally remained in the $4 million to $6 million range each quarter across the period shown.
  • Negative gross profit: Q1 2026 gross profit was negative $115,000, showing that revenue is not yet covering direct costs.
  • Cash burn remains significant: Operating cash flow was negative $4.6 million in Q1 2026, following negative $3.2 million in Q4 2025 and negative $3.4 million in Q3 2025.
  • Share dilution is ongoing: Common equity issuance has repeatedly funded the business, and weighted average shares have trended higher over time, which can pressure per-share value.

Longer-term trend: the balance sheet has improved in some periods because of financing and investment activity, but the underlying operating model has not yet produced durable profitability. In early 2024, Atomera held a larger investment portfolio and more cash, but by early 2026 liquid resources were lower than a year earlier after continued quarterly losses. That suggests the company is still dependent on capital markets or meaningful commercial progress to extend its runway.

Bottom line: Atomera is still in the “wait for commercialization” phase. The company’s cash position and low debt are positives, but the absence of meaningful revenue growth and continued operating losses are the main risks. Investors will likely focus on new customer wins, licensing traction, and whether management can convert the technology story into recurring revenue before the cash balance erodes further.

07/07/26 03:13 PM ETAI Generated. May Contain Errors.

Atomera Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Atomera's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Atomera's net income appears to be on an upward trend, with a most recent value of -$20.17 million in 2025, rising from -$9.51 million in 2015. The previous period was -$18.44 million in 2024. View Atomera's forecast to see where analysts expect Atomera to go next.

Atomera's total operating income in 2025 was -$21.12 million, based on the following breakdown:
  • Total Gross Profit: -$256 thousand
  • Total Operating Expenses: $20.87 million

Over the last 10 years, Atomera's total revenue changed from $0.00 in 2015 to $65 thousand in 2025, a change of 6,500,000.0%.

Atomera's total liabilities were at $2.71 million at the end of 2025, a 33.0% decrease from 2024, and a 83.6% decrease since 2015.

In the past 10 years, Atomera's cash and equivalents has ranged from $3.20 million in 2015 to $37.94 million in 2020, and is currently $19.21 million as of their latest financial filing in 2025.

Over the last 10 years, Atomera's book value per share changed from -10.41 in 2015 to 0.58 in 2025, a change of -105.6%.



Financial statements for NASDAQ:ATOM last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners